Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms

Molecular Cancer Therapeutics - Tập 15 Số 6 - Trang 1376-1386 - 2016
Hannah R. Wardill1,2, Rachel J. Gibson1,3, Ysabella Van Sebille2, Kate R. Secombe2, Janet K. Coller4, I. White2, Jim Manavis5, Mark R. Hutchinson2,6, Vasiliki Staikopoulos2, Richard M. Logan7, Joanne M. Bowen2
11Discipline of Anatomy and Pathology, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
22Discipline of Physiology, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
33Division of Health Sciences, University of South Australia, Australia.
44Discipline of Pharmacology, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
55Adelaide Centre for Neuroscience Research and Discipline of Anatomy and Pathology, University of Adelaide, Adelaide, South Australia, Australia.
66Australian Research Council Centre of Excellence for Nanoscale Biophotonics, Adelaide, South Australia, Australia.
77School of Dentistry, University of Adelaide, Adelaide, South Australia, Australia.

Tóm tắt

Abstract

Strong epidemiological data indicate that chemotherapy-induced gut toxicity and pain occur in parallel, indicating common underlying mechanisms. We have recently outlined evidence suggesting that TLR4 signaling may contribute to both side effects. We therefore aimed to determine if genetic deletion of TLR4 improves chemotherapy-induced gut toxicity and pain. Forty-two female wild-type (WT) and 42 Tlr4 null (−/−) BALB/c mice weighing between 18 and 25 g (10–13 weeks) received a single 270 mg/kg (i.p.) dose of irinotecan hydrochloride or vehicle control and were killed at 6, 24, 48, 72, and 96 hours. Bacterial sequencing was conducted on cecal samples of control animals to determine the gut microbiome profile. Gut toxicity was assessed using validated clinical and histopathologic markers, permeability assays, and inflammatory markers. Chemotherapy-induced pain was assessed using the validated rodent facial grimace criteria, as well as immunologic markers of glial activation in the lumbar spinal cord. TLR4 deletion attenuated irinotecan-induced gut toxicity, with improvements in weight loss (P = 0.0003) and diarrhea (P < 0.0001). Crypt apoptosis was significantly decreased in BALB/c-Tlr4−/−billy mice (P < 0.0001), correlating with lower mucosal injury scores (P < 0.005). Intestinal permeability to FITC-dextran (4 kDa) and LPS translocation was greater in WT mice than in BALB/c-Tlr4−/−billy (P = 0.01 and P < 0.0001, respectively). GFAP staining in the lumbar spinal cord, indicative of astrocytic activation, was increased at 6 and 72 hours in WT mice compared with BALB/c-Tlr4−/−billy mice (P = 0.008, P = 0.01). These data indicate that TLR4 is uniquely positioned to mediate irinotecan-induced gut toxicity and pain, highlighting the possibility of a targetable gut/CNS axis for improved toxicity outcomes. Mol Cancer Ther; 15(6); 1376–86. ©2016 AACR.

Từ khóa


Tài liệu tham khảo

Lalla, 2014, MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy, Cancer, 120, 1453, 10.1002/cncr.28592

Carlotto, 2013, The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue, PharmacoEconomics, 31, 753, 10.1007/s40273-013-0081-2

Sonis, 2004, The pathobiology of mucositis, Nat Rev Cancer, 4, 277, 10.1038/nrc1318

Chabot, 1997, Clinical pharmacokinetics of irinotecan, Clin Pharmacokinet, 33, 245, 10.2165/00003088-199733040-00001

Stringer, 2008, Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats, Cancer Biol Ther, 7, 1919, 10.4161/cbt.7.12.6940

Stringer, 2009, Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile, Int J Exp Pathol, 90, 489, 10.1111/j.1365-2613.2009.00671.x

Stringer, 2009, Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis, Exp Biol Med, 234, 430, 10.3181/0810-RM-301

Wardill, 2014, TLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?, Int J Cancer, 135, 2483, 10.1002/ijc.28656

Wardill, 2015, Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity, Cancer Treat Rev, 41, 122, 10.1016/j.ctrv.2014.11.005

Al-Dasooqi, 2013, Emerging evidence on the pathobiology of mucositis, Support Care Cancer, 21, 2075, 10.1007/s00520-013-1810-y

Fukata, 2005, Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis, Am J Physiol Gastrointest Liver Physiol, 288, G1055, 10.1152/ajpgi.00328.2004

De Nardo, 2015, Toll-like receptors: activation, signalling and transcriptional modulation, Cytokine, 74, 181, 10.1016/j.cyto.2015.02.025

Jacobsen, 2014, Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction, Int Rev Neurobiol, 118, 129, 10.1016/B978-0-12-801284-0.00006-3

Bowen, 2012, Expression of TLRs in the rat intestine following chemotherapy for cancer, Brain Behaviour Immunity, 26, S27, 10.1016/j.bbi.2012.07.120

Gibson, 2016, Chemotherapy-induced gut toxicity and pain: involvement of TLRs, Support Care Cancer, 24, 2251, 10.1007/s00520-015-3020-2

Aprile, 2008, Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy, Cancer, 112, 284, 10.1002/cncr.23182

Phipps, 2009, Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses, Am J Respir Crit Care Med, 179, 883, 10.1164/rccm.200806-974OC

Gibson, 2007, Establishment of a single-dose irinotecan model of gastrointestinal mucositis, Chemotherapy, 53, 360, 10.1159/000107458

Sotocinal, 2011, The Rat Grimace Scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions, Mol Pain, 7, 55

Mathijssen, 2001, Clinical pharmacokinetics and metabolism of irinotecan (CPT-11), Clin Cancer Res, 7, 2182

Zhang, 2014, PEAR: a fast and accurate Illumina Paired-End reAd mergeR, Bioinformatics, 30, 614, 10.1093/bioinformatics/btt593

Caporaso, 2010, QIIME allows analysis of high-throughput community sequencing data, Nat Methods, 7, 335, 10.1038/nmeth.f.303

Edgar, 2010, Search and clustering orders of magnitude faster than BLAST, Bioinformatics, 26, 2460, 10.1093/bioinformatics/btq461

Edgar, 2011, UCHIME improves sensitivity and speed of chimera detection, Bioinformatics, 27, 2194, 10.1093/bioinformatics/btr381

Howarth, 1996, Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats, J Nutr, 126, 2519, 10.1093/jn/126.10.2519

Keefe, 2000, Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans, Gut, 47, 632, 10.1136/gut.47.5.632

Helps, 2012, Automatic nonsubjective estimation of antigen content visualized by immunohistochemistry using color deconvolution, Appl Immunohistochem Mol Morphol, 20, 82, 10.1097/PAI.0b013e31821fc8cd

Bland, 2005, The analysis of cross-tabulation, An introduction to medical statistics

Stringer, 2013, Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases, Support Care Cancer, 21, 1843, 10.1007/s00520-013-1741-7

Hufeldt, 2010, Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors, Comp Med, 60, 336

Kuehbacher, 2008, Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease, J Med Microbiol, 57, 1569, 10.1099/jmm.0.47719-0

Pedroso, 2015, Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice, Microbiology, 161, 1950, 10.1099/mic.0.000149

Kurita, 2011, Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen, Cancer Chemother Pharmacol, 67, 201, 10.1007/s00280-010-1310-4

Gibson, 2008, MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis, Cell Microbiol, 10, 618, 10.1111/j.1462-5822.2007.01071.x

Frank, 2015, TLR signaling modulates side effects of anticancer therapy in the small intestine, J Immunol, 194, 1983, 10.4049/jimmunol.1402481

Afrazi, 2014, Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis, J Biol Chem, 289, 9584, 10.1074/jbc.M113.526517

Deng, 2013, Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis, J Immunol, 190, 5152, 10.4049/jimmunol.1300496

Pathak, 2006, TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages, J Immunol, 177, 7950, 10.4049/jimmunol.177.11.7950

Hayashi, 2001, The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, 410, 1099, 10.1038/35074106

Shoenfelt, 2009, Involvement of TLR2 and TLR4 in inflammatory immune responses induced by fine and coarse ambient air particulate matter, J Leukoc Biol, 86, 303, 10.1189/jlb.1008587

Holmes, 2013, Trying to unravel the mysteries of chemobrain, Lancet Neurol, 12, 533, 10.1016/S1474-4422(13)70087-5

Ji, 2013, Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model, PLoS One, 8, e60733, 10.1371/journal.pone.0060733

Apetoh, 2007, Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nat Med, 13, 1050, 10.1038/nm1622

Huang, 2014, The TLR4/NF-kappaB signaling pathway mediates the growth of colon cancer, Eur Rev Med Pharmacol Sci, 18, 3834

Yang, 2010, Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion, J Exp Clin Cancer Res, 29, 92, 10.1186/1756-9966-29-92

Jain, 2015, TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells, Prostate, 75, 1020, 10.1002/pros.22983

Farzi, 2015, Toll-like receptor 4 contributes to the inhibitory effect of morphine on colonic motility in vitro and in vivo, Sci Rep, 5, 9499, 10.1038/srep09499

Anitha, 2012, Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling, Gastroenterology, 143, 1006, 10.1053/j.gastro.2012.06.034